| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5972bec91115958634b84fd69fa5816c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c45f3f15395ecd80506aa6c37fe3cb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-03 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0607 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate |
2013-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_539b99739e3703afab0e66dffb50c9a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0decbffc4364a628ded509dd7495c1f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b57563500eb2aa2c1c0c11b8e1d0092a |
| publicationDate |
2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015196600-A1 |
| titleOfInvention |
Pluripotent stem cell that induces repair and regeneration after myocardial infarction |
| abstract |
An object of the present invention is to provide a novel medical application for use in regenerative medicine that uses pluripotent stem cells (Muse cells). The present invention provides a cell preparation for treating myocardial infarction, and particularly serious massive myocardial infarction and heart failure associated therewith, that contains pluripotent stem cells positive for SSEA-3 isolated from biological mesenchymal tissue or cultured mesenchymal cells. The cell preparation of the present invention is based on a cardiac tissue regeneration mechanism by which Muse cells are made to selectively accumulate in damaged myocardial tissue and differentiate into cardiac muscle in that tissue as a result of intravenous administration of Muse cells to a subject presenting with the aforementioned disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110302212-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376544-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022313741-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000552-B2 |
| priorityDate |
2012-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |